$2125 | SAVE $375 | Single User
$4250 | SAVE $750 | Site License
$6375 | SAVE $1,125 | Enterprise License

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016
[Published by Global Data]

Published by Global Data: 29 Jul 2016 | 27246 | In Stock
Related Topics: Cancer , Clinical Trials , Ovarian Cancer

Introduction

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Ovarian Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Countries Contributing to Clinical Trials in Middle East and Africa 12

    Clinical Trials by G7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 14

    Clinical Trials in G7 Countries by Trial Status 15

    Clinical Trials by E7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 16

    Clinical Trials by Phase in E7 Countries 17

    Clinical Trials in E7 Countries by Trial Status 18

    Clinical Trials by Phase 19

    In Progress Trials by Phase 20

    Clinical Trials by Trial Status 21

    Clinical Trials by End Point Status 22

    Subjects Recruited Over a Period of Time 23

    Clinical Trials by Sponsor Type 24

    Prominent Sponsors 25

    Top Companies Participating in Metastatic Ovarian Cancer Therapeutics Clinical Trials 26

    Prominent Drugs 28

    Latest Clinical Trials News on Metastatic Ovarian Cancer 29

    Jul 28, 2016: Use Of Parsortix In GANNET53 Drug Trial In Ovarian Cancer 29

    Clinical Trial Profile Snapshots 30

    Appendix 101

    Abbreviations 101

    Definitions 101

    Research Methodology 102

    Secondary Research 102

    About GlobalData 103

    Contact Us 103

    Disclaimer 103

    Source 104

List Of Tables
in Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 [Published by Global Data]

List of Tables

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 6

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Metastatic Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12

Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 13

Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 16

Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 19

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Metastatic Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List Of Figures, Charts and Diagrams
in Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 [Published by Global Data]

List of Figures

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Metastatic Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 13

Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

Metastatic Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 16

Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Metastatic Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20

Metastatic Ovarian Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Metastatic Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

Metastatic Ovarian Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

GlobalData Methodology 102

Additional Details

Publisher

Global Data

Publisher Information

Reference

27246 | GDHC3623CTIDB

Number of Pages

104

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial r...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016
Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016
Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial ...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical ...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H2, 2016
Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H2, 2016SummaryGlobalData's...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial r...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016
Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical ...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H2, 2016
Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H2, 2016SummaryGlobalData's...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Physician Views: Avastin to lose share as front-line therapy for first-line metastatic colorectal cancer?
Scope Two recent developments appear poised to shift the typical US-based treatment regimen for firs...
13 Jul 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...